Company intelligence / Profile preview

Structura Capital

Toronto, Ontario, Canadastructuragroup.com ↗

Ownership: Private
Development stage: Other

Overview

Structura Biotechnology develops CryoSPARC, an AI-powered software suite for high-throughput 3D visualization of proteins using cryo-electron microscopy. The technology accelerates structure-based drug discovery by providing rapid protein structure determination capabilities to academic labs and pharmaceutical companies worldwide. The company has filed patents related to biological databases, molecular biology, nanotechnology, and protein structures. Clinical results are not applicable as the company does not develop therapeutics itself.

Therapeutic areas: OncologyNeurology
Modalities: proteinsbiologics
Industry: Drug Discovery Services

Partnerships

Academic institutions (customers)Major pharmaceutical companies (customers)

Beyond the preview

Go deeper on Structura Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Structura Capital.

Explore the full profile